반응식
[O:1]1[C@@:5]2([CH:10]3[CH2:11][CH2:12][N:7]([CH2:8][CH2:9]3)[CH2:6]2)[CH2:4][NH:3][C:2]1=[O:13].Br[C:15]1[O:16][C:17]([Si:21]([CH3:24])([CH3:23])[CH3:22])=[C:18]([Br:20])[CH:19]=1>>[Br:20][C:18]1[CH:19]=[C:15]([N:3]2[CH2:4][C@:5]3([CH:10]4[CH2:11][CH2:12][N:7]([CH2:8][CH2:9]4)[CH2:6]3)[O:1][C:2]2=[O:13])[O:16][C:17]=1[Si:21]([CH3:24])([CH3:23])[CH3:22]참가 물질
3
실험 절차
The title compound was prepared by a method analogous to that described in Preparation 3 from (S)-spiro[1-azabicyclo[2.2.2]octan-3,5′-oxazolidin]-2′-one and 2,4-dibromo-5-(trimethylsilyl)furan. The title compound (577 mg) was obtained as a pale yellow solid, m/z 399, 401 (MH+).
후처리
- customThe title compound was prepared by a method analogous to
출처 및 근거
- ORD 기록
- ord-6a2058fad94c45feacee301b7c4d013a
- 출처 데이터셋
- uspto-grants-2009_04
- 특허 번호
- US07514567B2
연결된 노트
불러오는 중…